Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomized, Double-Blind. Placebo-Controlled, Multi-Center Study of Systemic Lupus Erythematosus With Acute Severe SLE Flares Excluding Renal or Neurological Systems

NCT00111306 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT00111306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00111306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomized, Double-Blind. Placebo-Controlled, Multi-Center Study of Systemic Lupus Erythematosus With Acute Severe SLE Flares Excluding Renal or Neurological Systems
Lead sponsor
UCB Pharma
Phase
Phase 3
Overall status
Terminated
Start date
June 30, 2005
Completion date
March 31, 2007
Enrollment
510
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus